Avery Dennison Corp: Form 10-K for the period ended Dec 28, 2019
Filed with the SEC on Feb 26, 2020 and accepted by EDGAR at Feb 26, 2020, 16:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-09-29 to 2019-12-28 | $1.77bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 12 months2018-12-30 to 2019-12-28 | $7.07bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2018-12-30 to 2019-12-28 | $5.17bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-09-29 to 2019-12-28 | $484.7m | us-gaap:GrossProfit |
| Gross profit | 12 months2018-12-30 to 2019-12-28 | $1.90bn | us-gaap:GrossProfit |
| Research and development | 12 months2018-12-30 to 2019-12-28 | $92.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2018-12-30 to 2019-12-28 | $1.08bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 12 months2018-12-30 to 2019-12-28 | $75.8m | us-gaap:InterestExpense |
| Income tax | 12 months2018-12-30 to 2019-12-28 | −$56.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-09-29 to 2019-12-28 | $162.5m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 12 months2018-12-30 to 2019-12-28 | $303.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-09-29 to 2019-12-28 | $1.92 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2018-12-30 to 2019-12-28 | $3.57 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-09-29 to 2019-12-28 | $1.95 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2018-12-30 to 2019-12-28 | $3.61 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2018-12-30 to 2019-12-28 | 85,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2018-12-30 to 2019-12-28 | $746.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2018-12-30 to 2019-12-28 | $219.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2018-12-30 to 2019-12-28 | $189.7m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2018-12-30 to 2019-12-28 | $237.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-12-28 | $253.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-28 | $2.34bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-28 | $5.49bn | us-gaap:Assets |
| Current liabilities | At period end2019-12-28 | $2.25bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2019-12-28 | $1.48bn | us-gaap:LongTermDebt |
| Current portion of debt | At period end2019-12-28 | $440.2m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2019-12-28 | $1.20bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-20-025360. Last ingested by Listed: Nov 10, 2026, 16:39 ET. Listed shows no prices and gives no investment advice.